drugset
drugset / Trial / NCT03814642

Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Male Participants

NCT03814642 ↗

Phase 1 Completed 25 enrolled HK inno.N Corporation
RandomizedCrossoverOpen-labelTreatment

Summary

This study aims to evaluate the influence of tegoprazan on the pharmacodynamics of clopidogrel according to CYP2C19 genotypes following co-administration of tegoprazan and clopidogrel in healthy male volunteers.

Timeline

Start
2019-01-21
Primary completion
2019-07-22
Completion
2019-07-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Clopidogrel Small molecule 75 mg Oral
Subject Esomeprazole Small molecule 20 mg Oral
Subject Tegoprazan Other / unclassified 50 mg Oral

Indications

No indication recorded.